# Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia

> **NCT01082588** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorders
- Schizophreniform Disorders

## Interventions

- **DRUG:** Pravastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01082588
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082588, "Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01082588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*